老虎证券

美股详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

神经分泌生物科学

120.56
-2.4000-1.95%
盘前：120.560.00000.00%04:08 EDT
成交量：96.48万
成交额：1.17亿
市值：119.31亿
市盈率：40.77
高：122.42
开：122.42
低：119.79
收：122.96
数据加载中...
总览公司新闻公告
2021/04/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report
2020/11/24

重要事件披露

8-K - Current report
2020/11/19

重要事件披露

8-K - Current report
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/09/10

重要事件披露

8-K - Current report
2020/08/28

重要事件披露

8-K - Current report
2020/08/03

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/03

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
更多